Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Prelude Therapeutics Inc | EVP and Chief of Business Oper | Common Stock | 3.75K | $14.1K | $3.77 | Sep 2, 2021 | Direct |
Prelude Therapeutics Inc | EVP and Chief of Business Oper | Employee Stock Option (right to buy) | 208K | Sep 2, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PRLD | Prelude Therapeutics Inc | Sep 2, 2021 | 5 | -$490K | 4 | Sep 7, 2021 | EVP and Chief of Business Oper |
PRLD | Prelude Therapeutics Inc | Jul 20, 2021 | 1 | $0 | 4 | Jul 22, 2021 | EVP and Chief of Business Oper |